Fig. 1
From: The role of CD28 in the prognosis of young lung adenocarcinoma patients
Basic information of young Chinese patients with lung adenocarcinoma (LUAD) and IHC of the tumor immune microenvironment (TIME). a Positive PD-L1 staining; b Negative PD-L1 staining; c The stratification of the MOD of PD-L1 staining between 2 groups of patients; d Positive CD28 staining; e Negative CD28 staining; f The stratification of the MOD of CD28 staining between 2 groups of patients; g Positive CD3 staining (center of the tumor); h Positive CD3 staining (invasive margins); i Negative CD3 staining; j The stratification of the MOD of CD3 staining between 2 groups of patients